Skip to content
Home/ Crispr-Cas-Based Genome Editing for Treating Human Diseases - Part B: Volume 210
Crispr-Cas-Based Genome Editing for Treating Human Diseases - Part B: Volume 210

Crispr-Cas-Based Genome Editing for Treating Human Diseases - Part B: Volume 210

No customer reviews yet ISBN 9780443224201 Academic Press

CRISPR-Cas-Based Genome Editing for Treating Human Diseases, Part B represents CRISPR-Cas systems for genome editing. Currently, CRISPR-Cas systems have been proven to be a key technology for targeted genome editing, which is acting as a simple, rapid, and cost-effective solution. Chapters in this release include Current approaches in CRISPR -Cas systems for metabolic disorders, Recent progress in CRISPR -Cas systems for CRISPR for retinal diseases, Recent progress in CRISPR -Cas systems for cataract and blindness, Advances in CRISPR -Cas systems for muscular dystrophy, Recent development in CRISPR -Cas systems for cardiac disease, Current approaches in CRISPR -Cas systems for diabetes, and much more.

Additional sections cover Advances in CRISPR -Cas systems for liver disease, Advances in CRISPR -Cas systems for lung disease, Advances in CRISPR -Cas systems for kidney diseases, Current progress in CRISPR -Cas systems for rare disease, Advances in CRISPR -Cas systems for heredity disease, Recent progress in CRISPR -Cas systems for neurological disorders, and CRISPR challenges in clinical developments.

About the author

Product details

BrandAcademic Press
Pub dateJan 22, 2025
ISBN-10044322420X
ISBN-139780443224201
Hardcover308.0 pages
LanguageEnglish
Dimensions9 × 0.96 × 6 in
Weight1 lb
Last updated 2026-04-24 21:47
$197.81
In stock — ships in 24 hours with free tracking
Delivery by Monday, September 14, 2026
Qty
Sign in to Add to Saved list
Free delivery on orders over $35.
15-day returns. Any reason.
Secure checkout. We never store card details.

Readers who bought this also bought

More from Life Sciences - Molecular Biology
See all